Menu
Back to Journals » Lung Cancer: Targets and Therapy » Volume 12
Review
Immunotherapy for Stage III NSCLC: Durvalumab and Beyond
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 9,642 | Dovepress* | 7,052+ | 204 | 7,256 | |
| PubMed Central* | 2,590 | 379 | 2,969 | ||
| Totals | 9,642 | 583 | 10,225 | ||
| *Since 2 November 2021 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 19 | 0 | 0 | 1 | 8 | 10 |
View citations on PubMed Central and Google Scholar